Inflarx received a deficiency notice for violating the Minimum Bid Price Rule on Nasdaq Stock Market on July 12, 2025.
1 report, 1 independent
Updated Jul 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Inflarx received a deficiency notice for violating the Minimum Bid Price Rule on Nasdaq Stock Market on July 12, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Inflarx (Germany)
company in Jena, Germany
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireInflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement JENA, Germany, July 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company